Finance

Beta
Lists
DSGN:NASDAQ
Design Therapeutics Inc
$10.76
+3.07%
(+0.32) 1D
$10.76
0.00% (0.00)
After hours
Closed: Jun 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSGN...
Open
$10.44
High
$10.88
Low
$10.43
Mkt. cap
672.04M
Avg. vol.
1.12M
Volume
388.36K
52-wk high
$17.25
52-wk low
$3.33
EPS
-$1.19
Beta
1.63
Shares outstanding
62.46M
No. of employees
54
Open
$10.44
High
$10.88
Low
$10.43
Mkt. cap
672.04M
Avg. vol.
1.12M
Volume
388.36K
52-wk high
$17.25
52-wk low
$3.33
EPS
-$1.19
Beta
1.63
Shares outstanding
62.46M
No. of employees
54
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to DSGN in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for DSGN in the last 3 months.
Highest
Current $10.76
$22.00 (+104.46%)
Average
$19.60 (+82.16%)
Lowest
$15.00 (+39.41%)
News stories
From sources across the web
About Design Therapeutics Inc
CEO-
Employees54
Founded2017
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websitedesigntx.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.29 / -$0.34
+13.69%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
15.74M
14.59M
13.42M
14.38M
Cost of revenue
15.74M
14.59M
13.42M
14.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.83M
4.72M
4.74M
5.33M
Operating expense
5.83M
4.72M
4.74M
5.33M
Total operating expenses
21.57M
19.31M
18.17M
19.71M
Operating income
-21.57M
-19.31M
-18.17M
-19.71M
Other non operating income
-
-
-
-
EBT including unusual items
-19.08M
-17.00M
-16.00M
-17.64M
EBT excluding unusual items
-19.08M
-17.00M
-16.00M
-17.64M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.08M
-17.00M
-16.00M
-17.64M
Net profit margin
-
-
-
-
Earnings per share
-0.34
-0.30
-0.27
-0.29
Interest and investment income
2.49M
2.31M
2.17M
2.07M
Interest expense
-
-
-
-
Net interest expenses
2.49M
2.31M
2.17M
2.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.42M
-19.16M
-18.01M
-19.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer